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Abstract
Cerebrospinal fluid (CSF) analysis is an important tool in the diagnostic work-up of many neurological disorders, but
reference ranges for CSF glucose, CSF/plasma glucose ratio and CSF lactate based on studies with large numbers of CSF
samples are not available. Our aim was to define age-specific reference values. In 1993 The Nijmegen Observational CSF
Study was started. Results of all CSF samples that were analyzed between 1993 and 2008 at our laboratory were
systematically collected and stored in our computerized database. After exclusion of CSF samples with an unknown or
elevated erythrocyte count, an elevated leucocyte count, elevated concentrations of bilirubin, free hemoglobin, or total
protein 9,036 CSF samples were further studied for CSF glucose (n = 8,871), CSF/plasma glucose ratio (n = 4,516) and CSF
lactate values (n = 7,614). CSF glucose, CSF/plasma glucose ratio and CSF lactate were age-, but not sex dependent. Age-
specific reference ranges were defined as 5–95th percentile ranges. CSF glucose 5th percentile values ranged from 1.8 to
2.9 mmol/L and 95th percentile values from 3.8 to 5.6 mmol/L. CSF/plasma glucose ratio 5th percentile values ranged from
0.41 to 0.53 and 95th percentile values from 0.82 to 1.19. CSF lactate 5th percentile values ranged from 0.88 to 1.41 mmol/L
and 95th percentile values from 2.00 to 2.71 mmol/L. Reference ranges for all three parameters were widest in neonates and
narrowest in toddlers, with lower and upper limits increasing with age. These reference values allow a reliable interpretation
of CSF results in everyday clinical practice. Furthermore, hypoglycemia was associated with an increased CSF/plasma
glucose ratio, whereas hyperglycemia did not affect the CSF/plasma glucose ratio.
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Introduction
Cerebrospinal fluid (CSF) analysis is an important tool in the
diagnostic work-up of neurological disorders like infection or
inflammation of the central nervous system, intracranial hemor-
rhage and inherited metabolic disorders. It is therefore remarkable
that little consensus exists amongst different laboratories about the
reference ranges for CSF glucose and lactate [1]. CSF glucose is
decreased in, amongst others, patients with bacterial meningitis
and leptomeningeal carcinomatosis, usually in combination with
other abnormal CSF parameters, such as an elevated leucocyte
count, total protein or lactate concentration [2–4]. Low CSF
glucose, often in combination with low CSF lactate, can also be
found in patients with GLUT1 deficiency syndrome, a treatable
genetic metabolic disorder that is caused by impaired glucose
transport into brain [5]. CSF lactate can be elevated in several
disorders, such as subarachnoidal hemorrhage, bacterial menin-
gitis [3], cerebral hypoxia [6], status epilepticus [7], and inborn
errors of metabolism [8]. Age-specific reference values are needed
for an accurate interpretation of the results of CSF analysis and
differential diagnosis. The main objective of this study was to
define age-dependent reference values for CSF glucose, CSF/
plasma glucose ratio and CSF lactate for everyday clinical
practice. Furthermore, we aimed to determine the correlations
between CSF glucose or CSF/plasma glucose ratio and plasma
glucose in order to gain a better understanding of the dynamics of
glucose transport of glucose into brain under physiological as well
as pathological (i.e. hypo- and hyperglycemic) conditions.
Methods
Literature study
We performed an extensive literature search using PubMed for
studies on the subject of reference values for CSF glucose, CSF/
plasma glucose ratio and CSF lactate by using MeSH terms
(cerebrospinal fluid, analysis, glucose, CSF/plasma glucose ratio,
lactate, reference value). Furthermore, we studied the relevant
references mentioned in the articles.
CSF samples
In September 1993 The Nijmegen Observational CSF was
started. Results of all CSF samples that were analyzed at the
laboratory of our tertiary referral hospital, the Radboud University
Nijmegen Medical Centre in Nijmegen, The Netherlands (www.
neurochemistry.nl) were systematically collected and stored in our
computerized database. This study was approved by the local
Medical Ethical Committee, METC Arnhem – Nijmegen. Since
laboratory data had routinely been stored in the hospital database
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and were anonymously processed for the purpose of this study, the
METC waived the need for patient informed consent. CSF
samples that were analyzed between September 1993 and
December 2008 (n= 23,618) were included. To define reference
values for glucose and lactate in CSF obtained by lumbar puncture
we have excluded (1) all CSF samples from patients from the
neurosurgical ward or intensive care units (where CSF is often
obtained from ventricular shunts); and CSF samples with (2) an
erythrocyte count $200/mL or unknown erythrocyte count; (3) a
bilirubin concentration $0.5 mmol/L and/or a free hemoglobin
concentration $0.25 mmol/L; (4) an elevated leucocyte count; or
(5) an elevated total protein concentration (Fig. 1). We have used
strict exclusion criteria for leucocyte count and total protein
concentration based on age-specific reference values as given in
figure 1 [9–12]. In a previous study we identified all patients with
GLUT1DS in our CSF database (n = 3) [13]. These patients were
excluded from the present study. We finally included 9,036 CSF
samples for further analyses. Patient population consisted of 49.7%
males and 50.3% females. The population was predominantly
Caucasian.
CSF glucose was determined in 8,871 CSF samples, CSF/
plasma glucose ratio in 4,518 samples and CSF lactate concen-
trations in 7, 614 CSF samples. To determine whether multiple
lumbar punctures from the same patient influenced our results, we
have in second instance also studied the CSF glucose (n = 7,245)
and CSF lactate (n = 6,856) concentrations if only the first CSF
sample of each patient was included.
In second instance, the 5–95th percentile ranges were deter-
mined after exclusion of (1) CSF samples from patients with
hypoglycaemia (defined as plasma glucose ,3.0 mmol/L), hyper-
glycemia (defined as plasma glucose .7.8 mmol/L) or unknown
plasma glucose level at the moment of lumbar puncture (Fig. 1); (2)
CSF samples with a clearly elevated CSF lactate (arbitrarily
defined as .3000 mmol/L).
CSF analysis
Lumbar punctures were performed in everyday clinical practice,
thus on any time of the day, using standard procedures, and
preferably after a ‘fasting’ period of at least 4–6 hours. CSF was
collected in polypropylene tubes and was immediately transported
after withdrawal to the adjacent laboratory. The CSF samples
were analyzed within two hours after sample collection. After cell
count, CSF was centrifuged at 860 g at room-temperature and
glucose, lactate, total protein and blood pigments concentrations
were analyzed the same day.
CSF glucose was measured by the hexokinase method [14].
CSF glucose was measured linearly until 10.9 mM with a limit of
detection (LOD) of 0.056 mM, a cients of variation (CV) of
,1.6% and a recovery of 97–100%.
The CSF lactate concentration was determined by the
enzymatic conversion of NAD into NADH, measured at
340 nm, in the presence of lactate dehydrogenase. CSF lactate
was measured linear until 13.32 mM with a LOD of 0.020 mM,
cients of variation (CV) ,1.2% and a recovery of 98–100%.
Total protein concentration in CSF was determined with the
Lowry reaction and absorbance is measured at 720 nm. Lactate,
glucose and total protein were analyzed with an automated
analyzer (Mira Plus; ABX, Eindhoven, The Netherlands). The
laboratory participates in external quality control programs of
Instand (Du¨sseldorf, Germany) for the quality control of the
glucose, lactate and total protein analyses. Results are available
upon request. CSF erythrocytes and leucocytes count were
determined manually in a Fuchs-Rosenthal counting chamber.
Assay methods were completely validated if the method was
altered during the inclusion period (e.g. change in detection
device) and were evaluated according to the QC-system (ISO
15189).
Plasma glucose analysis
The allowed time frame for parallel sampling of plasma and
CSF was 30 minutes. Glucose was measured in plasma by the
hexokinase method [14]. Venous blood was sampled in NaF-
EDTA tubes and transported on room temperature.
Statistical analysis
Statistical analyses were performed using SPSS version 20.0
(SPSS INC, Chicago, IL, USA). Patients were divided into age
groups which are commonly used in daily clinical practice (as used
by MeSH, Pubmed) (Table 1). We included all 9,036 CSF samples
of which 8,871 samples were studied for CSF glucose, 4,516
samples for CSF/plasma glucose ratio and 7,614 samples for CSF
lactate values. Reference values for CSF glucose, CSF/plasma
glucose ratio and CSF lactate were based on the 5–95th data-
observed percentile ranges. 95% Confidence Intervals were based
on Bootstrap Percentiles (based on 1000 bootstrap samples).
Results
Literature study
Reference ranges for CSF glucose, CSF/plasma glucose ratio
and CSF lactate based on studies including large numbers of CSF
samples were not available. Most studies had been performed in
newborn or young infants and were based on a small number of
patients (i.e. ,350 patients) and only a few had been performed in
patients without an explicit neurological disorder. We have
summarized the results of our literature study in Table 2. In all
studies CSF glucose was measured by the hexokinase method and
CSF lactate was determined enzymatically.
CSF glucose concentrations
CSF glucose concentrations were measured in 8,871 out of
9,036 (98%) CSF samples. CSF glucose ranged from 1.0 to
11.9 mmol/L (mean 3.42 mmol/L; SD 0.769). CSF glucose
concentrations were age-dependent with remarkably low 5th
percentile values until the age of 6 months (1.7–2.0 mmol/L)
(Fig. 2A and Table S1). After the age of 6 months the CSF glucose
5th percentile values gradually increased over the entire age range
studied (from 2.4 to 2.9 mmol/L). CSF glucose 95th percentile
values were highest in neonates (5.6 mmol/L) and lowest in
patients aged 3–6 months (3.9 mmol/L) and 3–4 years
(3.8 mmol/l). Above the age of 4 years a gradual increase in the
CSF glucose 95th percentile was seen (from 4.0 to 6.1 mmol/L).
After exclusion of CSF samples from patients with an abnormal or
unknown plasma glucose level at the moment of lumbar puncture,
the CSF glucose 5th percentile value did not show a change of
.10% of the original value. CSF glucose 95th percentile values,
however, did change more than 10% in patients aged 4–8 weeks,
3–12 months and $60 years after the application of these
exclusion criteria. Numbers were unaffected in the other age
groups.
CSF/plasma glucose ratio
Plasma glucose was measured in 4,516 out of 9,036 (50%)
paired samples and ranged from 0.80 to 40.4 mmol/L (mean
5.5 mmol/L; SD 1.98). An elevated plasma glucose (.7.8 mmol/
L) was found in 338 samples (7.5%). Plasma glucose was elevated
in 13.5% of the samples from patients older than 50 years of age,
compared to 3.7% in samples from patients younger than 50 years
Reference Values for CSF Glucose and Lactate
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Figure 1. Flow chart of inclusion of CSF samples. N – number of CSF samples.
doi:10.1371/journal.pone.0042745.g001
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of age. A lowered plasma glucose (defined as ,3.0 mmol/L) was
found in 24 samples (0.5%) of patients aged 0–78 years (mean 19.4
years; SD 22.9).
The CSF/plasma glucose ratio is described in Fig. 2B and Table
S2. CSF/plasma glucose ratio ranged from 0.17 to 2.03 (mean
0.65; SD 0.14). Low CSF/plasma glucose ratio 5th percentile
values were seen below the age of 6 months (0.36–0.42) and in
children aged 3–4 years (0.43) compared to neighboring age
groups. Above the age of 4 years the CSF/plasma glucose 5th
percentile values gradually increased from 0.44 to 0.46 until the
age of 40 years, with a continuous decrease afterwards to 0.35.
CSF/plasma glucose ratio 95th percentiles were high in patients
below the age of 12 months (1.03–1.38).
After exclusion of CSF samples from patients with abnormal
(defined as .7.8 mmol/L or ,3.0 mmol/L) or unknown plasma
glucose level, CSF/plasma glucose ratio 95th percentiles were
.10% lower compared to the original value in patients below the
age of 4 weeks, whereas .10% higher 5th percentile values were
found in patients older than 50 years of age. Numbers were
unaffected in the other age groups.
CSF lactate concentrations
CSF lactate concentrations were measured in 7,614 out of 9,036
(84%) CSF samples. CSF lactate ranged from 0.16 to 12.5 mmol/
L (mean 1.7; SD 0.48) CSF lactate showed a clear age-dependent
pattern (Fig. 2C and Table S3). CSF lactate 5th percentile
concentrations were, like CSF glucose, remarkably low in (young)
children (0.86–1.14 mmol/L) and increased with age. CSF lactate
95th percentile values were particularly high in neonates
(3.4 mmol/L) and low in children aged 6 months to 10 years
(2.0–2.1 mmol/L). After the age of 18 years a gradual increase of
the 95th percentile value was seen from 2.2 to 2.7 mmol/L.
Exclusion of CSF samples with a CSF lactate value of
.3000 mmol/L did not lead to a change of .10% of the original
value of the 5th of 95th percentile value, except in patients under
the age of 4 weeks and in patients aged 3–6 months.
Age-specific reference values
If multiple CSF samples from the same patient were excluded
and only the first CSF sample of each patient was included, the 5th
and 95th percentile ranges for CSF glucose (n = 7,245), CSF/
plasma glucose ratio (n = 3,862) and CSF lactate (n = 6,856) values
did not change .10% compared to the original value). Age-
specific reference values were therefore based on the 5th and 95th
percentile ranges of all CSF samples (8,871 CSF samples for CSF
glucose; 4,516 samples for CSF/plasma glucose ratio and 7,614
samples for CSF lactate) (Table 1). Reference ranges for CSF
glucose, CSF/plasma glucose ratio and CSF lactate did not differ
between males and females.
Relation between plasma glucose, CSF glucose and CSF/
plasma glucose ratio
A linear relation between plasma glucose and CSF glucose was
found (Figure 3A). Hypoglycemia was associated with an increased
CSF/plasma glucose ratio in most patients, whereas hyperglyce-
mia was associated with only a minimal decrease of the CSF/
plasma glucose ratio in the majority of the samples (Figure 3B).
Discussion
Our study allowed for the first time to define age-specific
reference values for CSF glucose, CSF lactate and CSF/plasma
glucose for children and adults based on a large number of CSF
samples. Reference ranges did not differ between males and
females, which is in line with previous findings [15]. To our best
knowledge, no studies are available reporting differences in CSF
glucose or lactate based on race. We therefore believe that our
data, mainly based on CSF samples from Caucasians, can be
generalized to non-Caucasians.
Table 1. Age-specific reference values for CSF glucose, CSF/plasma glucose ratio and CSF lactate.
Age CSF glucose CSF/plasma glucose CSF lactate
mmol/L mmol/L
Neonate 0–4 weeks 1.9–5.6 0.42–1.10 (1.38)* 0.9–2.5 (3.4){
Infant 4–8 weeks 1.7–5.6 (5.1)* 0.36–1.20 0.9–2.2
2–6 months 1.9–4.9 (3.9)* 0.39–1.10 1.0–2.2 (3.3){
6–12 months 2.4–4.9 (4.3)* 0.44–1.05 1.1–2.2
Toddler 1–3 years 2.4–4.2 0.44–0.84 1.0–2.0
Preschool child 3–4 years 2.4–3.8 0.43–0.86 1.0–2.0
School child 4–10 years 2.5–4.0 0.45–0.84 1.1–2.1
(Pre)adolescent 10–18 years 2.6–4.3 0.47–0.83 1.2–2.2
Young adult 18–30 years 2.7–4.4 0.46–0.90 1.2–2.2
Adult 30–50 years 2.8–4.4 0.46–0.88 1.3–2.4
Middle aged 50–60 years 2.8–4.2 (4.8)* (0.43) 0.48–0.87* 1.3–2.5
Aged 60–80 years 2.9–4.4 (5.6)* (0.42) 0.46–0.84* 1.4–2.6
$80 years 2.9–4.5 (6.1)* (0.35) 0.42–0.81* 1.4–2.7
Reference values are based on the 5th to 95th percentile values. The subgroups from the original data (see Tables S1,S2,S3) were clustered into age groups which are
commonly used in daily clinical practice (as used by MeSH, Pubmed).
*Reference range after exclusion of CSF samples of patients with an unknown or abnormal plasma glucose (,3.0 mmol/L or .7.8 mmol/L) at the moment of lumbar
puncture (only represented if .10% different from to the original value). Numbers between brackets represent values without correction for plasma glucose.
{Reference range after exclusion of CSF samples with CSF lactate .3000 mmol/L (only represented if.10% different from the original value). Number between brackets
represents upper limit without exclusion of CSF samples with CSF lactate .3000 mmol/L.
doi:10.1371/journal.pone.0042745.t001
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Since it seems impossible to obtain CSF from healthy volunteers
(especially children) under standardized conditions (e.g. after
fasting), we included CSF samples from our computerized
database of patients with a medical indication for a lumbar
puncture, which reflects the daily clinical practice. Because of the
large number of samples it was not feasible to obtain clinical
information from the patients. In order to exclude as many as
possible CSF samples of patients with overt neurological disorders,
we have therefore used strict exclusion criteria based on other CSF
parameters (Fig. 1). Furthermore, since the concentrations of CSF
glucose and CSF lactate in ventricular CSF differ from lumbar
CSF values, we have excluded all ventricular CSF samples.
The reference range for CSF glucose is generally set at 2.5–
4.4 mmol/L, but ranges with a lower limit of 2.0 mmol/L or an
upper limit of 6.5 mmol/L are used as well [1,16]. We found an
age-dependent pattern for CSF glucose with 5th percentile values
ranging from 1.7 to 2.9 mmol/L and 95th percentile values from
4.5 to 5.6 mmol/L. Age-dependency of CSF glucose had been
described before in children [17]. CSF glucose 5th percentile
values were remarkably low until the age of 6 months (1.7–
2.0 mmol/L), which is in line with previous studies [9,18]
(Table 2). The 95th percentile value in our study was especially
high in neonates (5.6 mmol/L), which is higher than previously
Figure 3. Relation between plasma glucose and CSF glucose.
(A) Relation between plasma glucose and CSF/plasma glucose ratio in
4,508 CSF samples. CSF samples with CSF/plasma glucose ratio .1.5
(n = 5) are not shown. (B) Relation between plasma glucose and CSF
glucose in 4,513 CSF samples. The grey areas indicates normoglycemia
(plasma glucose .3.0 and ,7.8 mmol/L).
doi:10.1371/journal.pone.0042745.g003
Figure 2. Age-specific CSF glucose, CSF/plasma glucose ratio
and CSF lactate values. (A) CSF glucose concentration in 8,871
samples. CSF samples with CSF glucose .10.0 mmol/L (n = 4) are not
shown; (B) CSF/plasma glucose in 4,516 samples. CSF samples with CSF/
plasma glucose .1.5 (n = 5) are not shown; (C) CSF lactate concentra-
tion in 7,614 samples. CSF samples with CSF lactate .5000 mmol/L
(n = 22) are not shown. Lines indicate 5th and 95th percentile values.
doi:10.1371/journal.pone.0042745.g002
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described (3.5–4.0 mmol/L) [18]. Low CSF glucose 5th percentile
values and high 95th percentile values in neonates in our study
might be related to the high frequency of hypoglycemia and
hyperglycemia in neonates, especially in preterm infants and
neonates with a low birth weight [19,20]. After exclusion of CSF
samples from patients with abnormal or unknown plasma glucose
the 95th percentile values in infants aged 4 to 8 weeks and 3 to 12
months increased more than 10% compared to the original value.
This was due to a skewed distribution most likely caused by the
low number of CSF samples in these subgroups after exclusion of
samples with abnormal or unknown CSF glucose (Table S2).
CSF glucose 5–95th percentile values were relatively high in
patients older than 50 years of age. This was probably related to the
increasing frequency of hyperglycaemia in patients aged 50 years
and older (13.5% compared to 3.7% in patients younger than 50
years of age). In a study comparing the CSF/blood glucose ratio
from patients with diabetes mellitus and noninflammatory neuro-
logical conditions with patients with bacterial meningitis, the CSF
glucose ranged from 2.78 to 25 mmol/L in patients with diabetes,
with CSF/blood glucose ratio ranging from 0.20–3.46 [21]. To our
best knowledge no studies are available on CSF glucose and lactate
values in patients with diabetes without neurological disorders. In
order to correct the reference range for CSF glucose and CSF/
plasma glucose ratio for patients with abnormal plasma glucose, we
have in second instance excluded all patients with abnormal
(defined as .7.8 mmol/L or ,3.0 mmol/L) or unknown plasma
glucose. Reference ranges for CSF glucose before and after
correction for plasma glucose are described in Table 1.
The reference value for CSF/plasma glucose ratio is typically
about 0.6 and is generally set at 0.5–0.8 [15]. Our study confirms
this reference range, although a slight age-dependent pattern for
CSF/plasma glucose ratio was found. Below the age of 12 months
relatively low 5th percentile values were seen (0.36–0.44), whereas
95th percentiles were high in patients younger than 12 months
(1.05–1.20). A high CSF/plasma glucose ratio in newborns is
thought to be related to the higher cerebral blood flow in
newborns in combination with a smaller brain that utilizes less
glucose [22,23]. Remarkably, the upper reference limit of CSF/
plasma glucose values in patients under the age of 12 months in
our study exceeds 1.0. Most likely such high ratios are caused by a
decline in plasma glucose in the hours before the lumbar puncture,
while the concentration in the cerebrospinal fluid follows only
gradually. It is known that the equilibration of glucose between
plasma and CSF takes approximately two to four hours [24].
Figure 3A shows that a CSF/plasma glucose ratio exceeding 1.0 is
predominantly found in patients with hypoglycemia.
A linear correlation was found between plasma glucose (range
2.2–23.3 mmol/L) and CSF glucose (range 1.2–11.0 mmol/L),
with CSF glucose values exceeding 8 mmol/L in patients with
hyperglycemia. Whereas hypoglycemia was associated with an
increase of the CSF/plasma glucose ratio, hyperglycemia barely
affected the CSF/plasma glucose ratio (Fig. 3). This finding is in
contradiction with the general assumption that CSF glucose
concentrations tend to plateau at high blood glucose levels since
glucose is transported from blood into CSF by facilitated diffusion
and exhibits saturation kinetics [25]. Our study demonstrates that
in clinically relevant levels of hyperglycemia (i.e. plasma glucose
7.8–25 mmol/L), CSF glucose is linearly correlated with plasma
glucose.
The reference range for CSF lactate is generally set at 1.2–
2.1 mmol/L, but ranges from 0.6 to 3.1 mmol/L are used as well
(Table 2) [1]. We found a clear age-dependent pattern for CSF
lactate. A slight variation with age of the CSF lactate has been
described before in a study of children aged 0–15 years [26], with
95th percentile values around 1.95 mmol/L. Higher 95th percen-
tiles for children under the age of 6 months were found in the
present study (2.01–2.64 mmol/L). Furthermore, we observed
increasing 95th percentile values above the age of 40 years. The
tendency for CSF lactate to increase in adulthood (after the age of
54 years) has been described before in a study on cisternal CSF
specimens [15].
It is remarkable that after exclusion of all CSF samples with an
elevated erythrocyte or leucocyte count, bilirubin, free hemoglobu-
lin, or total protein concentration, 149 CSF samples with a lactate
concentrations .3000 mmol/L were found. CSF lactate concen-
trations can be raised in association with seizures, bactarial, fungal
of tuberculous meningitis or encephalitis, cerebral ischemia,
neurosarcoidosis, malignancy and metabolic disorders [27]. In
most of these disorders, however, other CSF parameters such as
leucocyte count and protein count are raised as well. It is possible
that some CSF samples from patients with a mitochondrial disorder
have been included, which will increase the 95th percentile range of
the reference range. We have therefore excluded CSF samples with
a CSF lactate concentration .3000 mmol/L in second instance.
This, however, did not change the 5–95th percentile value more
than10% compared to the original value, except for .10% lower
95th percentile value in patients younger than 4 weeks and patients
aged 3–6 months. For these patients we have therefore based the
reference range for CSF lactate on the CSF samples with CSF
lactate ,3000 mmol/L (Table 1).
CSF results for glucose and lactate can be especially helpful in
the diagnostic work-up of GLUT1 deficiency syndrome
(GLUT1DS), a neurometabolic disorder caused by defective
glucose transport into brain. With the exception of rare cases
[28–30], the biochemical hallmark of GLUT1DS uniformly
consists of low CSF glucose and lactate, and low CSF/plasma
ratio for glucose [5,13]. The availability of detailed, age-related
reference values as presented here will allow appropriate
interpretation of CSF and thereby identification of patients who
suffer from this treatable disorder.
In conclusion, we have defined age-specific reference values for
CSF glucose, CSF/plasma glucose ratio and CSF lactate. They
allow a reliable interpretation of CSF results in everyday clinical
practice.
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